GCS supports NorthEdge on its investment in ramarketing
GCS (formerly GRAPH Strategy) is pleased to have provided Commercial Due Diligence to NorthEdge Capital on its investment in ramarketing, a fast-growing life sciences marketing agency supporting clients across the global pharmaceutical and biotech sectors.
Headquartered in Newcastle, with offices in Manchester and Boston (MA), ramarketing provides brand, digital, content, and PR services to a global client base. The business has established itself as one of the world’s leading agencies in life sciences communications, helping customers build trust, visibility, and commercial success in highly regulated markets.
With NorthEdge’s investment, ramarketing will accelerate its international expansion, further enhance its creative and digital capabilities, and continue building out its US operations. The partnership will also support investment in talent and new service innovation to meet growing demand for data-driven, specialist marketing in the life sciences sector.
GCS’s work focused on assessing ramarketing’s market positioning, customer relationships, competitive differentiation, and growth potential across key life sciences verticals.
The GCS team on the transaction was led by James Tetherton and James Woolsey.
“We were delighted to support NorthEdge on this investment. ramarketing has built a strong reputation in the global life sciences sector through deep expertise and consistent delivery. The business is well placed to scale internationally and continue shaping how specialist marketing services add value in complex, regulated industries.”
— James Tetherton, Founding Partner, GCS
